Fucosterol
CAS No. 17605-67-3
Fucosterol( —— )
Catalog No. M21489 CAS No. 17605-67-3
Fucosterol is isolated from E. stolonifera with anti-diabetic anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 78 | In Stock |
|
| 10MG | 133 | In Stock |
|
| 25MG | 228 | In Stock |
|
| 50MG | 339 | In Stock |
|
| 100MG | 482 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameFucosterol
-
NoteResearch use only, not for human use.
-
Brief DescriptionFucosterol is isolated from E. stolonifera with anti-diabetic anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression.
-
DescriptionFucosterol is isolated from E. stolonifera with anti-diabetic anti-adipogenic and anti-cancer activities. It regulates adipogenesis via modulation of PPARα and C/EBPα expression.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPARα
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number17605-67-3
-
Formula Weight412.7
-
Molecular FormulaC29H48O
-
Purity>98% (HPLC)
-
SolubilityEthanol:16.67 mg/mL (4.39 mM)
-
SMILESCC(C)/C(/CC[C@@H](C)[C@@H](CC1)[C@@](C)(CC2)[C@@H]1[C@H]1[C@H]2[C@@](C)(CC[C@@H](C2)O)C2=CC1)=C/C
-
Chemical NameStigmasta-524(28)-dien-3-ol (3beta24E)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Jung HA et al. Anti-adipogenic activity of the edible brown alga Ecklonia stolonifera and its constituent fucosterol in 3T3-L1 adipocytes. Arch Pharm Res. 2014 Jun;37(6):713-20.
molnova catalog
related products
-
Pioglitazone hydroch...
Pioglitazone hydrochloride can increase both insulin-stimulated glucose uptake in peripheral tissues and insulin sensitivity in hepatic and adipose tissue.
-
LY518674
LY518674 decreases triglycerides and increases HDL-C and is used for the treatment of atherosclerosis.
-
GW 501516
A potent and subtype-selective PPARδ agonist with Ki of 1.1 nM in human PPARδ binding assay.
Cart
sales@molnova.com